@article{Kissling_E-2021_37669,
title = {Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021},
author = {Kissling, E. and Hooiveld, M. and Martin, V. and Martínez-Baz, I. and William, N. and Vilcu, A. and Mazagatos, C. and de Lusignan, S. and Meijer, A. and Machando, A. and Brytting, M. and Casado, I. and Murray, J. and Behillil, S. and Larrauri, A. and O'Donnell, J. and Tsang, R. and de Lange, M. and Rodrigues, A. and Riess, M. and Castilla, J. and Hamilton, M. and Falchi, A. and Pozo, F. and Dunford, L. and Cogdale, J. and Jansen, T. and Guiomar, R. and Enkirch, T. and Burgui, C. and Sigerson, D. and Blanchon, T. and Ochoa, E. and Connell, J. and Ellis, J. and van Gageldonk-Lafeber, R. and Kislaya, I. and Rose, A. and Valenciano, M. and team, I.},
month = {jul},
year = {2021},
abstract = {The I-MOVE-COVID-19 primary care/outpatient study sites are: England, France, Ireland, the Netherlands, Portugal, Scotland, Spain (three regions), Spain (Navarra region) and Sweden (Table 1). Study sites adapted the I-MOVE-COVID-19 VE study protocol [2], to their country-specific setting. Sites included all, or a systematic sample of, acute respiratory infection (ARI) patients or patients presenting with common COVID-19 symptoms (at least one of the following symptoms: fever, cough, shortness of breath, sudden onset of anosmia/ageusia) who contacted the sentinel physician (Table 1). The Navarra region included all patients presenting to the health service primary care physicians. A systematic sample of patients in COVID-19 testing centres both with and without physician referral were included in Portugal. Scotland included a systematic sample of patients presenting to community-based COVID-19 centres with self- and clinical staff-based swabbing.},
volume = {26},
issue = {29},
journal = {Eurosurveillance},
publisher = {European Centre for Disease Prevention and Control},
url = {https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100670},
}
